Estrogen production within the prostate gland has been a subject of considerable controversy for many years. We showed that estradiol concentration was 31.9, 63.2 and 25.1 pg/g in rat, dog and human prostate, respectively. We demonstrated estrogen formation from androst-4-ene-3, 17-dione in human, dog and rat prostate. (1) The kinetics of the aromatase of rat and dog prostate was measured using the
3H
2O-release assay. Aromatase activity increased with respect to incubation time, prostate tissue amount and substrate concentration. 4-hydroxyandrostenedione (4-OH-A) inhibited aromatization by 64-87% and 47-93% in rat and dog prostate, respectively. K
m and V
max values in rat prostate were 18.2nM and 16.2fmol estrogen/mg protein/hr compared to 7.6nM and 4.9fmol estrogen/mg protein/hr in dog prostate. The conversion rate from androstenedione to estrogen was 2.1% in rat prostate. (2) Estrogen production was determined in human and rat prostate using estrogen formation assay. The retention time of the estradiol 3-methyl ether fraction that was reduced and methylated from the estrone-containing fraction derivative was the same as that of natural estradiol 3-methyl ether. This fraction was recrystallized to achieve a constant specific activity. In human BPH tissue and rat prostate, production of estrone from androstenedione could be detected and conversion rates were 0.09% and 0.05%, respectively.
We conclude that aromatization of androgen exists in human, dog and rat prostate, and localized estrogen synthesis by the aromatase enzyme is an important aspect of steroid hormone action in the etiology of BPH.
View full abstract